跳至主要内容
临床试验/NCT05536323
NCT05536323尚未招募不适用

Comparison of the Incidence of Hypotension in Bolus Versus Continuous Administration of Remimazolam During Anesthesia Induction

Kangbuk Samsung Hospital0 个研究点目标入组 62 人开始时间: 2023年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
62
主要终点
Incidence of hypotension

研究概览

简要总结

Remimazolam is a newly introduced intravenous anesthetic, with rapid onset and offset. Although it is known to cause less hemodynamic instability, the incidence hypotension is the one of the most frequent adverse events with its use. For anesthetic induction, remimazolam can be used either as bolus dose or as continuous infusion.

This study is aimed to investigate the incidence of hypotension after anesthetic induction with bolus (0.14-0.33 mg/kg) or continuous (12 mg/kg/hr) remimazolam administration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • scheduled for elective surgery under general anesthesia
  • adult patient (over 19 years old)
  • American Society of Anesthesiology Physical Status I-III

排除标准

  • arrythmia
  • liver dysfunction
  • kidney dysfunction
  • uncontrolled hypertension
  • uncontrolled diabetes mellitus
  • allergic to benzodiazepines
  • heart failure
  • drug intoxication
  • alcohol intoxication

研究组 & 干预措施

Bolus

Experimental

Anesthetic induction with bolus remimazolam administration

干预措施: Remimazolam bolus (Drug)

Continuous

Experimental

Anesthetic induction with continuous remimazolam administration

干预措施: Remimazolam continuous (Drug)

结局指标

主要结局

Incidence of hypotension

时间窗: 10 minutes after anesthetic induction

Systolic pressure below 90 mmHg

次要结局

  • Incidence of bradycardia(10 minutes after anesthetic induction)
  • The lowest systolic blood pressure(10 minutes after anesthetic induction)
  • Number of participants with vasoactive drug use(10 minutes after anesthetic induction)
  • Time to loss of consciousness(10 minutes after anesthetic induction)
  • Dosage of remimazolam(10 minutes after anesthetic induction)

研究者

发起方
Kangbuk Samsung Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Eunah Cho, MD

Assistant Professor

Kangbuk Samsung Hospital

相似试验